It has also already been reported that COVID-19 induces an imbalance of RAS through viral-occupation of the angiotensin-converting enzyme 2 (ACE2) receptors, which reduces the generation of protective-peptides angiotensin-(1–7) and (1–9). Here, ACE2 is linked to COVID-19.